INDSWIFT LABORATORIES
Back to Balance Sheet
|
INDSWIFT LABORATORIES Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹221 Cr | ₹371 Cr | ₹334 Cr | ₹315 Cr | ₹323 Cr |
What is the latest Total Current Liabilities ratio of INDSWIFT LABORATORIES ?
Year | Total Current Liabilities |
---|---|
Mar2024 | ₹221 Cr |
Mar2023 | ₹371 Cr |
Mar2022 | ₹334 Cr |
Mar2021 | ₹315 Cr |
Mar2020 | ₹323 Cr |
How is Total Current Liabilities of INDSWIFT LABORATORIES Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹221 Cr | -40.37 | |
Mar2023 | ₹371 Cr | 10.95 | |
Mar2022 | ₹334 Cr | 6.34 | |
Mar2021 | ₹315 Cr | -2.65 | |
Mar2020 | ₹323 Cr | - |
Compare Total Current Liabilities of peers of INDSWIFT LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
INDSWIFT LABORATORIES | ₹787.2 Cr | 3.4% | -6.5% | -24.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹393,731.0 Cr | -4.3% | -3% | -0.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹172,373.0 Cr | -3.3% | -7.4% | 34.1% | Stock Analytics | |
CIPLA | ₹122,411.0 Cr | -4.4% | -0.5% | 0.7% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹122,285.0 Cr | 1.4% | 10.1% | 17.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹102,270.0 Cr | -5.2% | -5.7% | -5.9% | Stock Analytics |
INDSWIFT LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
INDSWIFT LABORATORIES | 3.4% |
-6.5% |
-24.6% |
SENSEX | -1.1% |
-3.4% |
-1.1% |
You may also like the below Video Courses